Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004772

Chief Financial Officer sold 50,000 shares at an average $68.61 ($3,430,421)

  • Chief Financial Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-01-19 Option exercise +50,000 $6.32 $316,000 51,000 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2021-01-19 Sale −17,634 $66.97 $1,180,949 33,366 D: show line 2 in the form
Cohen Chad M Chief Financial Officer 2021-01-19 Sale −4,581 $67.75 $310,363 28,785 D: show line 3 in the form
Cohen Chad M Chief Financial Officer 2021-01-19 Sale −6,695 $69.00 $461,955 22,090 D: show line 4 in the form
Cohen Chad M Chief Financial Officer 2021-01-19 Sale −14,201 $69.74 $990,378 7,889 D: show line 5 in the form
Cohen Chad M Chief Financial Officer 2021-01-19 Sale −6,889 $70.66 $486,777 1,000 D: show line 6 in the form
Open-market sales · 50,000 sh · avg $68.61 · $3,430,421

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Chad M Chief Financial Officer 2021-01-19 Option exercise · Stock Option (Right To Buy) −50,000 315,000 D: show line 7 in the form
Loading xslF345X03/doc4.xml…